Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients

Diabetes, Obesity and Metabolism

Volumn 10, Issue 10, 2008, Pages 970-972

  Aoki, K ^a   Nakajima, S ^b   Nezu, U ^a   Shinoda, K ^a   Terauchi, Yasuo ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nakajima Naika Clinic   (Japan)

Author keywords

Miglitol; Postprandial hyperglycaemia; glucosidase inhibitor

Indexed keywords

1,5 ANHYDROSORBITOL; ALPHA GLUCOSIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; MITIGLINIDE; PIOGLITAZONE; SULFONYLUREA;

ABDOMINAL DISCOMFORT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET THERAPY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; HYPOGLYCEMIA; INCIDENCE; LIVER FUNCTION; MEAL; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 52249086501     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00960.x     Document Type: Article

References (8)

1. Macfarlane DP, Paterson KR, Fisher M. Oral antidiabetic agents as cardiovascular drugs. Diabetes Obes Metab 2007; 9: 23-30.
2. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972.
3. Aoki K, Nakamura A, Ito S et al. Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients. Diabetes Res Clin Pract 2007; 78: 30-33.
4. Aoki K, Kato H, Terauchi Y. Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men. Endocr J 2007; 54: 1009-1014.
5. Dungan KM, Buse JB, Largay J et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006; 29: 1214-1219.
6. Rosak C, Nitzsche G, Konig P, Hofmann U. The effect of the timing and the administration of acarbose on postprandial hyperglycaemia. Diabet Med 1995; 12: 979-984.
7. Asakura T, Seino H, Nozaki S, Suzuki Y, Abe R. Effect of acarbose taken just before and after a meal on plasma glucose level in Japanese healthy subjects. Jpn J Hosp Pharm 1999; 25: 715-720.
8. Ho PM, Rumsfeld JS, Masoudi FA et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836-1841.